Biocad’s Asian Biosimilars Play Undaunted By Roche

Biocad has made significant strides in Vietnam with its biosimilar rituximab, and an anticipated “permanent registration” there is expected to unshackle limitations on imported supplies of the product. The Russian company tells Scrip that it is also planning to build its biosimilars presence in other Asian markets.